Pyxis Oncology Statistics
NASDAQ: PYXSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.01-0.01 (-0.50%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pyxis Oncology by the numbers
Pyxis Oncology has a market capitalization of $240.1 million based on 119.46M shares outstanding. With trailing EPS of $-1.40, Pyxis Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.7% below its 50-day average and 5.1% below its 200-day average.
Average daily trading volume is 1.26M shares, or about $2.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PYXS valuation vs. peer median
| Metric | PYXS | Peer median | Difference |
|---|---|---|---|
| Market cap | $240.11M | $240.52M | -0% |
| Avg. volume | 1.26M | 271.98K | +362% |
Peer median across 8 companies: CAMP, VOGX, AKBA, QTTB, VCRE, LFCR, SLGL, SIGA.
Valuation
- Market cap
- $240.11M
- EPS (TTM)
- $-1.40
- Shares outstanding
- 119.46M
Price and trading
- Previous close
- 2.02
- Open
- 2.02
- Day range
- 2.00 – 2.09
- 52-week range
- 1.03 – 5.55
- 52-week change
- -21.18%
- Beta
- —
- Volume
- 957.67K
- Average volume
- 1.26M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 240.11M
- Forward Pe
- -1.78
- Eps
- -1.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.55
- Week52 Low
- 1.03
- Avg Volume
- 1.26M
- Shares Outstanding
- 119.46M
- Ma50
- 3.13
- Ma200
- 2.12
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -63.78%
- Pct From52w Low
- 95.15%